市場調査レポート

商品コード

1529804

希少細胞分離の市場規模、シェア、動向分析レポート：製品タイプ別、細胞タイプ別、技術別、地域別、セグメント別予測、2024年～2030年

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030

出版日: 2024年07月19日 | 発行: Grand View Research

| ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 912,730円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,066,130円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,372,930円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=153.40円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

希少細胞分離市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の希少細胞分離の市場規模は、2024年から2030年にかけて9.71%のCAGRを記録し、2030年には34億6,000万米ドルに達すると予測されています。

この背景には、継続的な技術の進歩、慢性疾患の有病率の増加、個別化医療への需要の高まり、がん研究の進歩があります。さらに、希少幹細胞の分離は再生医療や幹細胞治療に不可欠であり、予測期間中の需要を促進しています。

COVID-19パンデミックは、診断と治療研究の進歩を加速させることで市場にプラスの影響を与えています。ウイルスを理解し、効果的な治療を開発する緊急の必要性が、最先端の細胞分離技術への投資を促し、希少な免疫細胞や循環ウイルス粒子の迅速な分離・分析を容易にしています。このように、需要の高まりはバイオテクノロジー業界全体の技術革新とコラボレーションを促進し、その結果、単一細胞分析、リキッドバイオプシー、個別化医療の機能が強化され、予測期間中の希少細胞分離の需要を押し上げています。

慢性疾患、特にがんの有病率の増加は、希少細胞分離技術に対する需要を大幅に増加させています。これらの細胞を分離することで、早期診断、治療効果のモニタリング、個々の患者に合わせた標的療法の開発が可能になります。これらの希少細胞を捕獲し治療することで、研究者や臨床医は特定の遺伝子変異を同定し、腫瘍の挙動を認識し、個別化された治療計画を立案し、最終的には患者の転帰を改善し、腫瘍学の分野を発展させることが期待されます。このように、挙動を予測するための希少細胞に対する需要の高まりが、予測期間中の市場成長を促進すると推定されます。

しかし、マイクロフルイディクスやフローサイトメトリーなどの高度な希少細胞分離技術には、多額の投資が必要となることが多いです。高額な装置、試薬、メンテナンスコストは、多くの研究機関や臨床ラボにとって法外な負担となり、市場の拡大を制限しています。さらに、希少細胞の分離に関わるプロセスは技術的に複雑であるため、専門的な知識やトレーニングが必要となります。この複雑さが採用の障壁となり、市場の成長をさらに妨げると予想されます。

希少細胞分離市場レポートハイライト

2023年は試薬・キット分野が市場を独占し、2024年から2030年にかけて最も速いCAGRで成長すると予測されます。細胞分離のための高度で高価な装置と比較した試薬・キットの費用対効果が、その普及に大きな役割を果たしています。
幹細胞型セグメントは2023年に39.46%の最大シェアを占めました。製薬業界やバイオテクノロジー業界は、新薬のスクリーニング、細胞反応の研究、潜在的な治療法の安全性評価のために、単離された幹細胞に大きく依存しています。このような研究および産業における広範な応用が、このセグメントの優位性を支えています。
2023年には、マイクロ流体ベースの技術セグメントが市場を独占しました。マイクロ流体技術の絶え間ない革新と進歩が、同市場における主導的地位の一因となっています。研究者や企業は、性能の向上、使いやすさ、他の分析ツールとの統合を提供する新しいマイクロ流体デバイスや手法を開発しています。こうした進歩がマイクロ流体ベースの細胞分離の普及と用途拡大を後押ししています。
北米は、がん罹患率の増加、座りがちなライフスタイル、慢性疾患の有病率の上昇により、2023年の市場を独占しています。一方、アジア太平洋は予測期間中に最も高いCAGRで成長すると予測されています。

セグメントダッシュボード
世界の希少細胞分離市場：細胞タイプ別変動分析
世界の希少細胞分離市場：規模と動向分析、細胞タイプ別、2018～2030年
循環腫瘍細胞
幹細胞
胎児細胞
希少免疫細胞
循環内皮細胞
その他の希少細胞タイプ

第6章希少細胞分離市場：技術別推定・動向分析

セグメントダッシュボード
世界の希少細胞分離市場：技術別変動分析
世界の希少細胞分離市場：規模と動向分析、技術別、2018～2030年
マイクロ流体技術
蛍光活性化細胞選別
磁気ビーズ分離

第7章希少細胞分離市場：地域別推定・動向分析

地域別市場シェア分析、2023年および2030年
地域別市場ダッシュボード
市場規模、予測動向分析、2018年から2030年：
北米
- 北米市場推計・予測2018～2030年
- 米国
- カナダ
- メキシコ
欧州
- 欧州市場推計・予測2018～2030年
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋
- アジア太平洋市場推計・予測2018～2030年
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
ラテンアメリカ
- ラテンアメリカ市場推計・予測2018～2030年
- ブラジル
- アルゼンチン
中東・アフリカ
- 中東・アフリカ市場推計・予測2018年から2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第8章競合情勢

企業/競合の分類
戦略マッピング
企業市況分析、2023年
企業プロファイル/上場企業
- Miltenyi Biotec
- Thermo Fisher Scientific, Inc.
- Danaher
- QIAGEN NV
- Bio-techne
- STEMCELL Technologies
- CELLENION
- RareCyte
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.

図表

List of Tables

1. List of abbreviation
2. Global rare cell isolation market, by region, 2018 - 2030 (USD Million)
3. Global rare cell isolation market, by product, 2018 - 2030 (USD Million)
4. Global rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
5. Global rare cell isolation market, by technology, 2018 - 2030 (USD Million)
6. North America rare cell isolation market, by country, 2018 - 2030 (USD Million)
7. North America rare cell isolation market, by product, 2018 - 2030 (USD Million)
8. North America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
9. North America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
10. U.S. rare cell isolation market, by product, 2018 - 2030 (USD Million)
11. U.S. rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
12. U.S. rare cell isolation market, by technology, 2018 - 2030 (USD Million)
13. Canada rare cell isolation market, by product, 2018 - 2030 (USD Million)
14. Canada rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
15. Canada rare cell isolation market, by technology, 2018 - 2030 (USD Million)
16. Mexico rare cell isolation market, by product, 2018 - 2030 (USD Million)
17. Mexico rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
18. Mexico rare cell isolation market, by technology, 2018 - 2030 (USD Million)
19. Europe rare cell isolation market, by country, 2018 - 2030 (USD Million)
20. Europe rare cell isolation market, by product, 2018 - 2030 (USD Million)
21. Europe rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
22. Europe rare cell isolation market, by technology, 2018 - 2030 (USD Million)
23. UK rare cell isolation market, by product, 2018 - 2030 (USD Million)
24. UK rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
25. UK rare cell isolation market, by technology, 2018 - 2030 (USD Million)
26. Germany rare cell isolation market, by product, 2018 - 2030 (USD Million)
27. Germany rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
28. Germany rare cell isolation market, by technology, 2018 - 2030 (USD Million)
29. France rare cell isolation market, by product, 2018 - 2030 (USD Million)
30. France rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
31. France rare cell isolation market, by technology, 2018 - 2030 (USD Million)
32. Italy rare cell isolation market, by product, 2018 - 2030 (USD Million)
33. Italy rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
34. Italy rare cell isolation market, by technology, 2018 - 2030 (USD Million)
35. Spain rare cell isolation market, by product, 2018 - 2030 (USD Million)
36. Spain rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
37. Spain rare cell isolation market, by technology, 2018 - 2030 (USD Million)
38. Denmark rare cell isolation market, by product, 2018 - 2030 (USD Million)
39. Denmark rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
40. Denmark rare cell isolation market, by technology, 2018 - 2030 (USD Million)
41. Sweden rare cell isolation market, by product, 2018 - 2030 (USD Million)
42. Sweden rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
43. Sweden rare cell isolation market, by technology, 2018 - 2030 (USD Million)
44. Norway rare cell isolation market, by product, 2018 - 2030 (USD Million)
45. Norway rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
46. Norway rare cell isolation market, by technology, 2018 - 2030 (USD Million)
47. Asia Pacific rare cell isolation market, by country, 2018 - 2030 (USD Million)
48. Asia Pacific rare cell isolation market, by product, 2018 - 2030 (USD Million)
49. Asia Pacific rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
50. Asia Pacific rare cell isolation market, by technology, 2018 - 2030 (USD Million)
51. Japan rare cell isolation market, by product, 2018 - 2030 (USD Million)
52. Japan rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
53. Japan rare cell isolation market, by technology, 2018 - 2030 (USD Million)
54. China rare cell isolation market, by product, 2018 - 2030 (USD Million)
55. China rare cell isolation market, by technology, 2018 - 2030 (USD Million)
56. China rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
57. India rare cell isolation market, by product, 2018 - 2030 (USD Million)
58. India rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
59. India rare cell isolation market, by technology, 2018 - 2030 (USD Million)
60. Australia rare cell isolation market, by product, 2018 - 2030 (USD Million)
61. Australia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
62. Australia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
63. South Korea rare cell isolation market, by product, 2018 - 2030 (USD Million)
64. South Korea rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
65. South Korea rare cell isolation market, by technology, 2018 - 2030 (USD Million)
66. Thailand rare cell isolation market, by product, 2018 - 2030 (USD Million)
67. Thailand rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
68. Thailand rare cell isolation market, by technology, 2018 - 2030 (USD Million)
69. Latin America rare cell isolation market, by country, 2018 - 2030 (USD Million)
70. Latin America rare cell isolation market, by product, 2018 - 2030 (USD Million)
71. Latin America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
72. Latin America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
73. Brazil rare cell isolation market, by product, 2018 - 2030 (USD Million)
74. Brazil rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
75. Brazil rare cell isolation market, by technology, 2018 - 2030 (USD Million)
76. Argentina rare cell isolation market, by product, 2018 - 2030 (USD Million)
77. Argentina rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
78. Argentina rare cell isolation market, by technology, 2018 - 2030 (USD Million)
79. MEA rare cell isolation market, by country, 2018 - 2030 (USD Million)
80. MEA rare cell isolation market, by product, 2018 - 2030 (USD Million)
81. MEA rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
82. MEA rare cell isolation market, by technology, 2018 - 2030 (USD Million)
83. South Africa rare cell isolation market, by product, 2018 - 2030 (USD Million)
84. South Africa rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
85. South Africa rare cell isolation market, by technology, 2018 - 2030 (USD Million)
86. Saudi Arabia rare cell isolation market, by product, 2018 - 2030 (USD Million)
87. Saudi Arabia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
88. Saudi Arabia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
89. UAE rare cell isolation market, by product, 2018 - 2030 (USD Million)
90. UAE rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
91. UAE rare cell isolation market, by technology, 2018 - 2030 (USD Million)
92. Kuwait rare cell isolation market, by product, 2018 - 2030 (USD Million)
93. Kuwait rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
94. Kuwait rare cell isolation market, by technology, 2018 - 2030 (USD Million)

List of Figures

1. Rare cell isolation market segmentation
2. Data analysis models
3. Market formulation and validation
4. Data validating & publishing
5. Market research process
6. Information procurement
7. Primary research
8. Value-chain-based sizing & forecasting
9. QFD modelling for market share assessment
10. Market formulation & validation
11. Commodity flow analysis
12. Market outlook
13. Segment snapshot-1
14. Segment snapshot-2
15. Competitive landscape snapshot
16. Market trends & outlook
17. Porter's five force analysis
18. PESTEL analysis
19. Rare cell isolation market: Products outlook key takeaways
20. Rare cell isolation market: Products movement analysis
21. Reagent & kits market estimates and forecasts, 2018 - 2030 (USD Million)
22. Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
23. Rare cell isolation market: Cell type outlook key takeaways
24. Rare cell isolation market: Cell type movement analysis
25. Circulating tumor cells market estimates and forecasts, 2018 - 2030 (USD Million)
26. Stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
27. Fetal cells market estimates and forecasts, 2018 - 2030 (USD Million)
28. Rare immune cells market estimates and forecasts, 2018 - 2030 (USD Million)
29. Circulating endothelial cells market estimates and forecasts, 2018 - 2030 (USD Million)
30. Other rare cell types market estimates and forecasts, 2018 - 2030 (USD Million)
31. Rare cell isolation market: Technology outlook key takeaways
32. Rare cell isolation market: Technology movement analysis
33. Magnetic bead separation market estimates and forecasts, 2018 - 2030 (USD Million)
34. Fluorescence-activated cell sorting market estimates and forecasts, 2018 - 2030 (USD Million)
35. Microfluidics-based techniques market estimates and forecasts, 2018 - 2030 (USD Million)
36. Regional marketplace outlook, 2023 & 2030 (USD Million)
37. Regional marketplace: Key takeaways
38. North America rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
39. Key country dynamics
40. U.S. rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
41. Key country dynamics
42. Canada rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
43. Key country dynamics
44. Mexico rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
45. Europe rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
46. Key country dynamics
47. UK rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
48. Key country dynamics
49. Germany rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
50. Key country dynamics
51. France rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
52. Key country dynamics
53. Spain rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
54. Key country dynamics
55. Italy rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
56. Key country dynamics
57. Denmark rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
58. Key country dynamics
59. Sweden rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
60. Key country dynamics
61. Norway rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
62. Asia Pacific rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
63. Key country dynamics
64. Japan rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
65. Key country dynamics
66. China rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
67. Key country dynamics
68. India rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
69. Key country dynamics
70. Australia rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
71. Key country dynamics
72. South Korea rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
73. Key country dynamics
74. Thailand rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
75. Key country dynamics
76. Market participant categorization
77. Rare cell isolation market position analysis, 2023
78. Strategic framework

Product Code: GVR-4-68040-359-9

Rare Cell Isolation Market Growth & Trends:

The global rare cell isolation market size is anticipated to reach USD 3.46 billion by 2030, registering a CAGR of 9.71% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the continuous technological advancements, increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in cancer research. Furthermore, the isolation of rare stem cells is essential for regenerative medicine and stem cell therapy, thereby propelling the demand over the forecast period.

The COVID-19 pandemic has positively impacted the market by accelerating diagnostics and therapeutic research advancements. The urgent need to understand the virus and develop effective treatments has stimulated investment in cutting-edge cell isolation technologies, facilitating the rapid isolation and analysis of rare immune cells and circulating viral particles. Thus, the growing demand has driven innovation and collaboration across the biotech industry, resulting in enhanced single-cell analysis, liquid biopsy, and personalized medicine capabilities, boosting the demand for rare cell isolation over the forecast period.

The increasing prevalence of chronic diseases, especially cancer, has significantly increased the demand for rare cell isolation techniques. Isolation of these cells allows for early diagnosis, monitoring of treatment efficacy, and development of targeted therapies tailored to individual patients. By capturing and studying these rare cells, researchers and clinicians are anticipated to identify specific genetic mutations, recognize tumor behavior, and devise personalized treatment plans, ultimately improving patient outcomes and advancing the field of oncology. Thus, the growing demand for rare cells in predicting behavior is estimated to propel the market growth over the forecast period.

However, advanced rare cell isolation technologies, such as microfluidics and flow cytometry, often require significant investment. The high equipment, reagents, and maintenance costs can be prohibitive for many research institutions and clinical labs, limiting market expansion. In addition, the processes involved in rare cell isolation are technically complex, thus requiring specialized expertise and training. This complexity is anticipated to create a barrier to adoption, further hampering the market's growth.

Rare Cell Isolation Market Report Highlights:

The reagent & kits segment dominated the market in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030. The cost-effectiveness of reagents and kits compared to more sophisticated and expensive equipment for cell isolation plays a significant role in their widespread adoption
The stem cell type segment held the largest share of 39.46% in 2023. The pharmaceutical and biotechnology industries rely heavily on isolated stem cells to screen for new drugs, study cellular responses, and assess the safety of potential treatments. This widespread application in research and industry underpins the segment dominance
The microfluidics-based techniques technology segment dominated the market in 2023. Continuous innovation & advancements in microfluidics technology contributed to its leading position in the market. Researchers and companies are developing new microfluidic devices and methods that offer improved performance, ease of use, and integration with other analytical tools. These advancements are driving widespread adoption and expanding the applications of microfluidics-based cell isolation
North America dominated the market in 2023 due to the growing cancer incidence, sedentary lifestyle, and rising prevalence of chronic diseases. On the other hand, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Products Segment
- 1.2.2. Cell Type Segment
- 1.2.3. Technology Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
- 1.8.1. Total Market: CAGR Calculation
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Rare cell isolation market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising prevalence of chronic and rare diseases
  - 3.2.1.2. Technological advancement and innovation in cell isolation
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Strict regulations and compliances for cell separation
3.3. Rare Cell Isolation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Rare Cell Isolation Market Products Movement Analysis
4.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Reagent & Kits
- 4.4.1. Reagent & kits market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Instrument
- 4.5.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Rare Cell Isolation Market Application Movement Analysis
5.3. Global Rare Cell Isolation Market Size & Trend Analysis, by cell type, 2018 to 2030 (USD Million)
5.4. Circulating Tumor Cells
- 5.4.1. Circulating tumor cells market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Stem Cells
- 5.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Fetal Cells
- 5.6.1. Fetal cells market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Rare Immune Cells
- 5.7.1. Rare immune cells market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Circulating Endothelial Cells
- 5.8.1. Circulating endothelial cells market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Other Rare Cell Types
- 5.9.1. Other rare cell types market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Rare Cell Isolation Market Technology Movement Analysis
6.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
6.4. Microfluidics-based Techniques
- 6.4.1. Microfluidics-based techniques market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Fluorescence-activated Cell Sorting
- 6.5.1. Fluorescence-activated cell sorting market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Magnetic Bead Separation
- 6.6.1. Magnetic bead separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Competitive scenario
  - 7.4.2.3. Regulatory framework
  - 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Competitive scenario
  - 7.4.3.3. Regulatory framework
  - 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Competitive scenario
  - 7.4.4.3. Regulatory framework
  - 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework
  - 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework
  - 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Competitive scenario
  - 7.5.4.3. Regulatory framework
  - 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Competitive scenario
  - 7.5.5.3. Regulatory framework
  - 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Competitive scenario
  - 7.5.6.3. Regulatory framework
  - 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Competitive scenario
  - 7.5.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.8. Sweden
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Competitive scenario
  - 7.5.8.3. Regulatory framework
  - 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.9. Norway
  - 7.5.9.1. Key country dynamics
  - 7.5.9.2. Competitive scenario
  - 7.5.9.3. Regulatory framework
  - 7.5.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. Regulatory framework
  - 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. Regulatory framework
  - 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Regulatory framework
  - 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. Regulatory framework
  - 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. South Korea
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Regulatory framework
  - 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Competitive scenario
  - 7.6.7.3. Regulatory framework
  - 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Regulatory framework
  - 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Competitive scenario
  - 7.7.3.3. Regulatory framework
  - 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Regulatory framework
  - 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Competitive scenario
  - 7.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Competitive scenario
  - 7.8.4.3. Regulatory framework
  - 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key country dynamics
  - 7.8.5.2. Competitive scenario
  - 7.8.5.3. Regulatory framework
  - 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
- 8.4.1. Miltenyi Biotec
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Danaher
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. QIAGEN N.V.
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Bio-techne
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. STEMCELL Technologies
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. CELLENION
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. RareCyte
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Illumina, Inc.
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Bio-Rad Laboratories, Inc.
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

希少細胞分離の市場規模、シェア、動向分析レポート：製品タイプ別、細胞タイプ別、技術別、地域別、セグメント別予測、2024年～2030年

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030

希少細胞分離市場の成長と動向：

希少細胞分離市場レポートハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章希少細胞分離市場の変数、動向、範囲

第4章希少細胞分離市場：製品別推定・動向分析

第5章希少細胞分離市場：細胞タイプ別推定・動向分析

第6章希少細胞分離市場：技術別推定・動向分析

第7章希少細胞分離市場：地域別推定・動向分析

第8章競合情勢

List of Tables

List of Figures

Rare Cell Isolation Market Growth & Trends:

Rare Cell Isolation Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Rare cell isolation market Variables, Trends & Scope

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

希少細胞分離の市場規模、シェア、動向分析レポート：製品タイプ別、細胞タイプ別、技術別、地域別、セグメント別予測、2024年～2030年

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030

希少細胞分離市場の成長と動向：

希少細胞分離市場レポートハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 希少細胞分離市場の変数、動向、範囲

第4章 希少細胞分離市場：製品別推定・動向分析

第5章 希少細胞分離市場： 細胞タイプ別推定・動向分析

第6章 希少細胞分離市場：技術別推定・動向分析

第7章 希少細胞分離市場：地域別推定・動向分析

第8章 競合情勢

List of Tables

List of Figures

Rare Cell Isolation Market Growth & Trends:

Rare Cell Isolation Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Rare cell isolation market Variables, Trends & Scope

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章希少細胞分離市場の変数、動向、範囲

第4章希少細胞分離市場：製品別推定・動向分析

第5章希少細胞分離市場：細胞タイプ別推定・動向分析

第6章希少細胞分離市場：技術別推定・動向分析

第7章希少細胞分離市場：地域別推定・動向分析

第8章競合情勢